Peregrine WORx
0

Complete Drug-Gene list for Top 20 drugs causing ADRs

05/19/2024 01:56 PM By Dr. Blair Curless


Know How the Top 20 Medications Interact in Your Body

We appreciate your interest in gaining a deeper understanding of the intricate interactions between medications and genetic biomarkers. 

Peregrine WORx is committed to empowering individuals with knowledge that enables informed healthcare decisions. In response to your request, we present the Comprehensive Drug-Gene Interaction List derived from our analysis of the top 20 genes and medications associated with adverse drug reactions.


This is a compilation of medications that are recommended by the FDA and PharmGKB that are actionable and require further testing. Their guidance is reflected by the level of evidence, with level A the strongest and level D the weakest. 


Table 1: FDA and PharmGKB Count of Actionable Medications List

PharmGKB: FDA column

Count

Actionable PGx

109

Testing required

71

No current recommendation

47

Informative PGx

11

Testing recommended

4

Grand Total

242




Table 2: Count of medications in each CPIC level


CPIC Level

Count of CPIC Level

A

44

A/B

7

B

60

B/C

13

C

24

D

2

No recommendation

92

Grand Total

242


Table 3: Genes matching up with the medications


Gene

Actionable Medication

CYP2C9

ibuprofen

CYP2D6

ondansetron

CYP2D6

codeine

CYP2D6

oxycodone

CYP2C9, G6PD, NAT2, NAT(not specific)

sulfamethoxazole-trimethoprim

G6PD

ciprofloxacin

CYP2C9

meloxicam

CYP2D6

dextromethorphan

CYP2D6

tramadol

G6PD

nitrofurantoin

CYP2C19

omeprazole

CYP2C19

pantoprazole

CYP2C19, CYP2D6

sertraline

CYP2C19, CYP2D6, SLC6A4

escitalopram

G6PD

levofloxacin

CYP2D6

metoprolol

ABCG2, SLCO1B1

rosuvastatin

CYP2C19

diazepam

CYP2D6

amphetamine

SLCO1B1

simvastatin


We believe that this comprehensive drug-gene interaction list will serve as a valuable resource in navigating the complexities of pharmacogenomics. The list may change over time due to new research and updated guidelines. Should you have any further questions or require additional information, our team at Peregrine WORx is here to assist you.


To review a list from the FDA, which is available publicly, to stay up to date, visit https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling


CPIC regularly updates their list of drug-gene guidelines available at https://cpicpgx.org/


PharmGKB is the Dutch Pharmacogenomics Working Group, CPIC, Canadian, French, and other professional societies annotated database, guidelines, and education platform for everyone to visit at https://www.pharmgkb.org/guidelineAnnotations


Liu D, Olson KL, Manzi SF, Mandl KD. Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics. Genet Med. 2021 Apr;23(4):782-786. doi: 10.1038/s41436-020-01044-2. Epub 2021 Jan 8. PMID: 33420348; PMCID: PMC9067543.


Cheers,

Blair Curless, PharmD, PhD

blair@peregrineworx.com

10719 Alpharetta Highway, #1388

Roswell, GA 30077

770-501-2001:o

404-500-0346:f

Peregrine WORx Tamvoes | LinkedIn: www.linkedin.com/blaircurless


Dr. Blair Curless

- Added to cart
- Can't add this product to the cart now. Please try again later.
- Quantity updated
- An error occurred. Please try again later.
Deleted from cart
- Can't delete this product from the cart at the moment. Please try again later.
Email IconVideo Chat IconPhone Call Icon